Equilis Prequenza Suspension for injection for horses Pack of 10 vials

Target species Horses Indications for use Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection. Onset of immunity: 2 weeks after completion of the primary vaccination course. Duration of immunity: 5 months after completion of the primary vaccination course. 12 months after the first revaccination. Contraindications None. Special warnings for each target species Foals should not be vaccinated before the age of 6 months, especially when born to mares that were revaccinated in the last two months of gestation, because of possible interference by maternally derived antibodies. Vaccinate healthly animals only. Special precautions for use Not applicable. Operator warnings In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Adverse reactions A diffuse hard or soft swelling (max. diameter 5 cm) may rarely occur at the injection site, regressing within 2 days. Pain at the injection site can occur in rare cases, which may result in temporary functional discomfort (stiffness). A local reaction exceeding 5 cm and possibly persisting longer than 2 days may occur in very rare cases. Fever, sometimes accompanied by lethargy and inappetence, may in very rare cases occur for 1 day, and up to 3 days in exceptional circumstances. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports). Use during pregnancy or lactation Can be used during pregnancy and lactation. Interactions No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.